Sort
23,748 grants matching “melanoma”
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
$441,457Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Pten/AKT and Siah in Regulation of Hypoxia
$441,443Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA
Acid Ceramidase, Target for Cancer
$441,419Xiang Liu · Sphingogene, Inc. · R41 · FY2009 · CA
Chemical Probes to Study Copper Biology
$441,375Christopher J. Chang · University Of California Berkeley · R01 · FY2023 · GM
CTL-based Immunotherapy in an Organotypic Melanoma Culture System
$441,335Dorothee M Herlyn · Wistar Institute · P50 · FY2008 · CA
The Function of CDK5 in Metastasis
$441,325Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2021 · CA
The Function of CDK5 in Metastasis
$441,325Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2019 · CA
The Function of CDK5 in Metastasis
$441,325Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Promoting Bim-driven apoptosis through MAPK inhibition: A therapeutic strategy in advanced melanoma
$441,168Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2019 · CA
The Antigen Targeting Core
$441,143Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Role of PTPRT in colon cancer progression and metastasis
$440,979Zhenghe Wang · Case Western Reserve University · R01 · FY2022 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$440,937Meenhard Herlyn · Wistar Institute · P50 · FY2023 · CA
Tumor Cell Dependence on Host Metabolism
$440,730Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2017 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$440,580Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2019 · CA
Multiscale anisotropy analysis of breast tissue subtypes from mammography and pathology
$440,561Andre Khalil · University Of Maine Orono · R15 · FY2025 · CA
NG2-PG in tumor vascularization and progression
$440,550Burnham Institute For Medical Research · R01 · FY2005 · CA
NG2-PG in tumor vascularization and progression
$440,550Burnham Institute For Medical Research · R01 · FY2004 · CA
NG2-PG in tumor vascularization and progression
$440,550Burnham Institute For Medical Research · R01 · FY2002 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer
$440,543Rohan Fernandes · George Washington University · R37 · FY2019 · CA
An integrated polymeric carrier for subunit cancer vaccines
$440,520Suzie H Pun · University Of Washington · R01 · FY2022 · CA
ST Louis-Cape Girardeau CCOP
$440,482Bethany Sleckman · St. John'S Mercy Medical Center · U10 · FY2007 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$440,336University Of Arizona · U10 · FY2002 · CA
B cells in autoimmunity following checkpoint blockade therapy
$440,314Kavita Dhodapkar · Emory University · R01 · FY2023 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$440,261Seok H Yun · Massachusetts General Hospital · R01 · FY2019 · CA
Computer aided diagnosis of cancer metastases in the brain
$440,259Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2017 · LM